2.87
Cardiff Oncology Inc 주식(CRDF)의 최신 뉴스
Cardiff Oncology Inc (CRDF) Has A Gold Mine On Its Hands - stocksregister.com
Lucid Capital Markets sets $14 target on Cardiff Oncology stock By Investing.com - Investing.com UK
Charles Schwab Investment Management Inc. Sells 19,629 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World
Is Cardiff Oncology, Inc. (CRDF) The Hot Biotech Stock Under $5? - Insider Monkey
Bank of New York Mellon Corp Increases Stock Holdings in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World
10 Hot Biotech Stocks Under $5 - Insider Monkey
Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze? - Mugglehead
Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: Wha - GuruFocus.com
Future Industry Growth Of Metastatic Prostate Cancer Market - openPR
Rhumbline Advisers Buys 10,290 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World
Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge - Canada NewsWire
Cardiff Oncology’s Earnings Call: Optimism Amid Challenges - MSN
Financial Review: Kymera Therapeutics (NASDAQ:KYMR) vs. Cardiff Oncology (NASDAQ:CRDF) - Defense World
All You Need to Know About Cardiff Oncology (CRDF) Rating Upgrade to Buy - Nasdaq
Q1 Earnings Forecast for CRDF Issued By William Blair - Defense World
Cardiff Oncology (NASDAQ:CRDF) Price Target Raised to $17.00 - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Cardiff Oncology (NASDAQ:CRDF) Stock - MarketBeat
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Cardiff Oncology (NASDAQ:CRDF) Announces Quarterly Earnings Results - MarketBeat
Cardiff Oncology plans mixed shelf offering - MSN
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2024 Earnings Call Transcript - Insider Monkey
Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Call Highlights: Fi - GuruFocus
Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Call Highlights: Financial Fortification and ... - Yahoo Finance
Cardiff Oncology Highlights Progress in Cancer Trials - TipRanks
Cardiff Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Cardiff Oncology Q4 2024 highlights strategic advances - Investing.com
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - The Manila Times
Cardiff Oncology Reports Positive Initial Efficacy Data for Onvansertib in Metastatic Colorectal Cancer and Secures $40 Million Financing - Nasdaq
Cardiff Oncology, Inc. SEC 10-K Report - TradingView
Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Cardiff Oncology Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Cardiff Oncology (CRDF) Projected to Post Earnings on Thursday - MarketBeat
Cardiff Oncology to Present at Upcoming Investor Conferences - The Manila Times
Can Cardiff Oncology's New Colorectal Cancer Approach Transform Treatment? CEO to Reveal Strategy - StockTitan
Critical Contrast: Cardiff Oncology (NASDAQ:CRDF) versus Vir Biotechnology (NASDAQ:VIR) - Defense World
Cardiff Oncology (CRDF) to Release Earnings on Thursday - Defense World
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update - The Manila Times
Can Cardiff Oncology's Q4 Earnings Reveal New Cancer Drug Progress? - StockTitan
Bullish Cardiff Oncology Insiders Rewarded As Their Investment Rises To US$1.81m - Yahoo Finance
Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Growth in Short Interest - MarketBeat
Taking on analysts’ expectations and winning: Cardiff Oncology Inc (CRDF) - SETE News
Cardiff Oncology: Pioneering RAS-Mutated Cancer Therapies With Onvansertib (NASDAQ:CRDF) - Seeking Alpha
Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Increase in Short Interest - Defense World
SG Americas Securities LLC Sells 6,103 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World
자본화:
|
볼륨(24시간):